673 related articles for article (PubMed ID: 10528183)
1. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
Shier P; Ngo K; Fung-Leung WP
J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
[TBL] [Abstract][Full Text] [Related]
2. Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice.
Manning TC; Rund LA; Gruber MM; Fallarino F; Gajewski TF; Kranz DM
J Immunol; 1997 Nov; 159(10):4665-75. PubMed ID: 9366389
[TBL] [Abstract][Full Text] [Related]
3. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.
Curtsinger JM; Lins DC; Mescher MF
J Immunol; 1998 Apr; 160(7):3236-43. PubMed ID: 9531279
[TBL] [Abstract][Full Text] [Related]
4. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand.
Abraham C; Griffith J; Miller J
J Immunol; 1999 Apr; 162(8):4399-405. PubMed ID: 10201975
[TBL] [Abstract][Full Text] [Related]
5. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
Sepulveda H; Cerwenka A; Morgan T; Dutton RW
J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
[TBL] [Abstract][Full Text] [Related]
6. Differential coupling of second signals for cytotoxicity and proliferation in CD8+ T cell effectors: amplification of the lytic potential by B7.
Krummel MF; Heath WR; Allison J
J Immunol; 1999 Sep; 163(6):2999-3006. PubMed ID: 10477562
[TBL] [Abstract][Full Text] [Related]
7. Increased threshold for TCR-mediated signaling controls self reactivity of intraepithelial lymphocytes.
Guehler SR; Finch RJ; Bluestone JA; Barrett TA
J Immunol; 1998 Jun; 160(11):5341-6. PubMed ID: 9605133
[TBL] [Abstract][Full Text] [Related]
8. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
9. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
Margenthaler JA; Flye MW
J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
[TBL] [Abstract][Full Text] [Related]
10. Functional similarity and differences between selection-independent CD4-CD8- alphabeta T cells and positively selected CD8 T cells expressing the same TCR and the induction of anergy in CD4-CD8- alphabeta T cells in antigen-expressing mice.
Caveno J; Zhang Y; Motyka B; Teh SJ; Teh HS
J Immunol; 1999 Aug; 163(3):1222-9. PubMed ID: 10415017
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
[TBL] [Abstract][Full Text] [Related]
12. Purified MHC class I and peptide complexes activate naive CD8+ T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions.
Goldstein JS; Chen T; Brunswick M; Mostowsky H; Kozlowski S
J Immunol; 1998 Apr; 160(7):3180-7. PubMed ID: 9531273
[TBL] [Abstract][Full Text] [Related]
13. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells.
Fields PE; Finch RJ; Gray GS; Zollner R; Thomas JL; Sturmhoefel K; Lee K; Wolf S; Gajewski TF; Fitch FW
J Immunol; 1998 Nov; 161(10):5268-75. PubMed ID: 9820499
[TBL] [Abstract][Full Text] [Related]
14. Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo.
Dubois PM; Pihlgren M; Tomkowiak M; Van Mechelen M; Marvel J
J Immunol; 1998 Nov; 161(10):5260-7. PubMed ID: 9820498
[TBL] [Abstract][Full Text] [Related]
15. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1.
Johnson KG; LeRoy FG; Borysiewicz LK; Matthews RJ
J Immunol; 1999 Apr; 162(7):3802-13. PubMed ID: 10201897
[TBL] [Abstract][Full Text] [Related]
16. The degree of CD8 dependence of cytolytic T cell precursors is determined by the nature of the T cell receptor (TCR) and influences negative selection in TCR-transgenic mice.
Auphan N; Curnow J; Guimezanes A; Langlet C; Malissen B; Mellor A; Schmitt-Verhulst AM
Eur J Immunol; 1994 Jul; 24(7):1572-7. PubMed ID: 8026519
[TBL] [Abstract][Full Text] [Related]
17. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
Chen FL; Kung JT
J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
[TBL] [Abstract][Full Text] [Related]
18. De novo-developed T cells have compromised response to existing alloantigens: using Ld-specific transgenic 2C T cells as tracers in a mouse heart transplantation model.
Luo H; Chen H; Qi S; Loh D; Daloze P; Veillette A; Xu D; Wu J
J Immunol; 1998 Jul; 161(1):73-82. PubMed ID: 9647209
[TBL] [Abstract][Full Text] [Related]
19. Characterization of anti-CD8-resistant cytolytic T lymphocytes induced by multivalent cross-linking of CD8 on precursor cells.
McCarthy SA; Kaldjian E; Singer A
J Immunol; 1989 Oct; 143(7):2112-9. PubMed ID: 2528588
[TBL] [Abstract][Full Text] [Related]
20. LFA-1 defect-induced effector/memory CD8+ T cell apoptosis is mediated via Bcl-2/Caspase pathways and associated with downregulation of CD27 and IL-15R.
Ye Z; Shi M; Xu S; Xiang J
Mol Immunol; 2010 Aug; 47(14):2411-21. PubMed ID: 20569988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
